AR007611A1 - Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek - Google Patents

Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek

Info

Publication number
AR007611A1
AR007611A1 ARP970102740A ARP970102740A AR007611A1 AR 007611 A1 AR007611 A1 AR 007611A1 AR P970102740 A ARP970102740 A AR P970102740A AR P970102740 A ARP970102740 A AR P970102740A AR 007611 A1 AR007611 A1 AR 007611A1
Authority
AR
Argentina
Prior art keywords
cell line
marek
disease virus
marek disease
line
Prior art date
Application number
ARP970102740A
Other languages
English (en)
Spanish (es)
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/670,272 external-priority patent/US5833980A/en
Application filed by Univ Michigan State filed Critical Univ Michigan State
Publication of AR007611A1 publication Critical patent/AR007611A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
ARP970102740A 1996-06-21 1997-06-20 Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek AR007611A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/670,272 US5833980A (en) 1995-10-27 1996-06-21 Sustainable cell line for the production of the Marek's disease vaccines

Publications (1)

Publication Number Publication Date
AR007611A1 true AR007611A1 (es) 1999-11-10

Family

ID=24689728

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102740A AR007611A1 (es) 1996-06-21 1997-06-20 Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek

Country Status (8)

Country Link
JP (1) JPH104956A (ja)
KR (1) KR980002250A (ja)
CN (1) CN1170760A (ja)
AR (1) AR007611A1 (ja)
AU (1) AU697814B2 (ja)
BR (1) BR9703544A (ja)
ID (1) ID19429A (ja)
MX (1) MX9702769A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857025C (en) * 2011-11-30 2021-08-03 Merial Limited Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
JP2013116869A (ja) * 2011-12-02 2013-06-13 Vaxxinova Kk 細胞内在ウイルスを主成分とする伝染性ファブリキウス嚢病生ワクチン
CN103977400B (zh) * 2014-05-29 2015-06-17 南京创启生物科技有限公司 一种用细胞系生产鸡马立克氏病活疫苗的方法

Also Published As

Publication number Publication date
AU2356897A (en) 1998-01-08
KR980002250A (ko) 1998-03-30
MX9702769A (es) 1997-12-31
ID19429A (id) 1998-07-09
JPH104956A (ja) 1998-01-13
BR9703544A (pt) 1998-09-29
CN1170760A (zh) 1998-01-21
AU697814B2 (en) 1998-10-15

Similar Documents

Publication Publication Date Title
BR9605153A (pt) Vacina de combinação para uso na proteção de galináceos contra a doença de newcastle kit de vacinação para imunizar galináceos contra a doença de newcastle e processo para a prevenção da doença de newcastle em galináceos
BR9912410A (pt) Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
CA2134835A1 (en) Live in ovo vaccine
DE69533305D1 (de) Lebende rekombinante Vogelvakzine auf eines Vogelherpesvirus gegründet, gegen Gumborokrankheit
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
AR044235A2 (es) Uso de una composicion que comprende merozoitos de eimeria vivos
PT712926E (pt) Virus da doenca pancreatica do peixe
AR007611A1 (es) Linea celular de pollo infectada con virus de la enfermedad de marek perdurable, metodo para producir la linea celular, vacuna para aves y lineacelular de herpesvirus de la enfermedad de marek
AR010794A1 (es) Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
MX9602256A (es) Vacuna contra la enfermedad de marek.
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
KR890014127A (ko) 생 조합 백신
BR9905779A (pt) Processos para preparação do vìrus da doença de marek utilizando linhagens de células contìnuas de aves
AU7680687A (en) Vaccines for fowl colibacillosis
AR012944A1 (es) Preparacion de virus de la enfermedad de marek usando lineas de celulas continuas de mamifero
PL341724A1 (en) Mutated newcastle disease virus (ndv) and method of obtaining same, live or inactivated vaccine containing same and method of obtaining such vaccine
ES2053732T3 (es) Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
PL346195A1 (en) Chicken anaemia virus (cav) of weakened patogenicity, vaccine for protecting poultry against cav and method of obtaining cav of weakened pathogenicity
HUP9802974A1 (hu) Fertőző bursitis elleni DNS-vakcina
RU94042470A (ru) Поливалентная вакцина для профилактики болезни марека и способ ее изготовления
BG100932A (en) Method for the preparation of cellular cultural inactivated vaccine against fowl pest
Nonnewitz Newcastle disease. A review on diagnosis, prophylaxis and vaccinations.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal